Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

A woman's male-pattern facial hair growth was caused by a rare malignant ovarian tumor that was difficult to diagnose and treat.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

A rare ovarian tumor caused high testosterone and excess hair in a woman, which was resolved after tumor removal.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

A woman's male-like physical changes were caused by two rare ovarian conditions.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

PCOS is linked to low-grade chronic inflammation.

circCFAP20DC helps goat ovarian cells grow, aiding follicle development.

MPA increases cancer spread by boosting Eph A2 activity.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

S100A4 promotes aggressive ovarian cancer and is a potential treatment target.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

A rare ovarian tumor in a 2-year-old girl was successfully removed, normalizing her hormone levels.

These ovarian conditions cause high testosterone levels.